ASSESSMENT OF THE RESPONSE OF PATIENTS WITH CROHN'S DISEASE TO BIOLOGICAL THERAPY USING NEW NON-INVASIVE MARKERS: lactoferrin and calprotectin
Arquivos de Gastroenterologia; NOGUEIRA, Islaine Martins; MISZPUTEN, Sender Jankiel; AMBROGINI Jr., Orlando; ARTIGIANI-NETO, Ricardo; CARVENTE, Claudia Teresa; ZANON, Maria Ivani.
; 50(2): 130-137, abr. 2013. tab
Artigo em Inglês | LILACS | ID: lil-679161
Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease.
Enteral nutritional therapy for induction of remission in Crohn's disease.
Diagnose und Monitoring bei chronisch-entzündlicher Darmerkrankung.
ACG Clinical Guideline: Management of Crohn's Disease in Adults.
Preventive therapy in postoperative Crohn's disease.
Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.
[Platelet count predicts therapeutic response of infliximab for active Crohn's disease].
Heat shock protein 90 and inflammatory activity in newly onset Crohn's disease.